What is Dar Al Dawa Development and Investment OCF Yield %?
Dar Al Dawa Development and InvestmentAMM:DADI 77 OCF Yield % is 30.72 as of Jul. 02, 2026, which is 180% above its 10-year median of 10.97. GuruFocus rates AMM:DADI with a GF Score™ of 77/100 and a GF Value™ of JOD1.10 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Dar Al Dawa Development and Investment ranks better than 96.52% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
AMM:DADI'
s OCF Yield % Range Over the Past 10 Years
Min: -3.68 Med: 10.97 Max: 39
Current: 30.72
During the past 13 years, the highest OCF Yield % of Dar Al Dawa Development and Investment was 39.00%. The lowest was -3.68%. And the median was 10.97%.
AMM:DADI's OCF Yield % is ranked better than 96.52% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 3.45
vs AMM:DADI: 30.72
Dar Al Dawa Development and Investment OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Dar Al Dawa Development and Investment OCF Yield % Related Terms
Dar Al Dawa Development and Investment OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dar Al Dawa Development and Investment OCF Yield % Chart
Dar Al Dawa Development and Investment Annual Data
AMM:DADI vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dar Al Dawa Development and Investment OCF Yield % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dar Al Dawa Development and Investment (AMM:DADI) has a OCF Yield % of 30.72 as of Jul. 02, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Dar Al Dawa Development and Investment and its competitors. This is 180% above median its historical median of 10.97. According to the industry distribution chart, Dar Al Dawa Development and Investment ranks #35 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 3.5%.
Is Dar Al Dawa Development and Investment's OCF Yield % too high?
Dar Al Dawa Development and Investment's current OCF Yield % of 30.72 is 180% above median its 10-year median of 10.97. The Drug Manufacturers industry median OCF Yield % is 3.45. Dar Al Dawa Development and Investment's value of 30.72 is 790.4% above this industry median. Based on the distribution chart, Dar Al Dawa Development and Investment ranks #35 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dar Al Dawa Development and Investment has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dar Al Dawa Development and Investment's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dar Al Dawa Development and Investment ranks #35 out of 1007 companies for OCF Yield %. This places Dar Al Dawa Development and Investment in the top 4% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.45. Dar Al Dawa Development and Investment's value of 30.72 is 790.4% above this benchmark. While the company's 10-year median is 10.97 vs. the industry median of 3.45, Dar Al Dawa Development and Investment has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.45, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dar Al Dawa Development and Investment's current OCF Yield % of 30.72 is 790.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Dar Al Dawa Development and Investment and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dar Al Dawa Development and Investment's current OCF Yield % is 30.72, which is 180% above median its own 10-year median of 10.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dar Al Dawa Development and Investment stock overvalued right now?
Based on GuruFocus' analysis, Dar Al Dawa Development and Investment (AMM:DADI) is currently considered Fairly Valued. The stock's GF Value™ is JOD1.10, compared to a current price of JOD1.14 — trading 3.6% above its estimated fair value. The current OCF Yield % is 30.72, which is 180% above median its 10-year median of 10.97 and 790.4% above the Drug Manufacturers industry median of 3.45. Dar Al Dawa Development and Investment's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Dar Al Dawa Development and Investment (AMM:DADI), the current OCF Yield % is 30.72 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dar Al Dawa Development and Investment (AMM:DADI) Overvalued in 2026?
Based on GuruFocus' analysis, Dar Al Dawa Development and Investment stock appears to be overvalued.
The current stock price of JOD1.14 is trading 3.6% above its estimated GF Value™ of JOD1.10.
GuruFocus considers Dar Al Dawa Development and Investment to be Fairly Valued.
Key valuation signals for AMM:DADI:
OCF Yield %: 30.72 (180% above median its 10-year median of 10.97)
GF Value™: JOD1.10 vs. price of JOD1.14 (3.6% above fair value)
Industry Position: 790.4% above the Drug Manufacturers median (#35 of 1007)
No single metric tells the full story. See the AMM:DADI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dar Al Dawa Development and Investment Business Description
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives are the production of medical, chemical, and pharmaceutical products, and importing pharmaceutical products. The subsidiaries' main objectives are marketing and distributing the Company's products, producing some specialized medical products, and investment activities. It offers products in the therapeutic areas of anti-infective, cardiovascular, diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
77GF Score
Get the complete analysis for AMM:DADI
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:DADI has been successfully added to your 
